References
- Zhang C C, Yang J M, Bash-Babula J, et al. DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4. Cancer Res 1999; 59: 3663–3670
- Grunberg S M, Jung M., Timblin C., et al. Increased cell death in a human lung adenocarcinoma cell line (1–549) after combined treatment with paclitaxel (P) and vinorelbine (V). Proc AACR 1999; 40: 17
- Ellis G E, Gralow J. R., Pierce H I, et al. Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: high complete response rate in a phase I-II study of doxorubicin-treated patients. J Clin Oncol 1999; 17: 1407–1412
- Krug M., Kris G. SC, Grant K K, et al. Phase II trial of dose dense docetaxel plus vinorelbine with prophylactic filgrastim (G-CSF) in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1999; 18: 460a